See every side of every news story
Published loading...Updated

Common Medications Impact Gut Microbiome and Promote Pathogen Growth

TÜBINGEN, GERMANY, JUL 16 – Study reveals one-third of common non-antibiotic drugs disrupt gut bacteria and promote Salmonella growth, urging drug safety evaluations to include microbiome impact, researchers say.

  • A new study published in Nature shows that many medications, including digoxin, are associated with microbiome alterations at the University of Tübingen, CMFI, and IMIT, directed by Professor Lisa Maier.
  • Addressing a healthcare paradox, the study analyzed 53 common non-antibiotic medications, including allergy remedies, antidepressants, and hormone drugs, over a fifteen-year cohort of over one million individuals.
  • In mouse experiments, digoxin, a cardiac glycoside, associated with elevated Salmonella rates, altered microbiome architecture, and fecal transplants confirmed increased infection susceptibility.
  • Consequently, and researchers urge clinicians and researchers to include microbial effects in drug safety evaluations.
  • Such insights emphasize the need to incorporate microbiome effects into future therapeutic strategies, and findings suggest developing interventions to mitigate microbiome–drug–pathogen interactions in vulnerable populations.
Insights by Ground AI
Does this summary seem wrong?

11 Articles

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 67% of the sources are Center
67% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Nature broke the news in United Kingdom on Wednesday, July 16, 2025.
Sources are mostly out of (0)